HAL (France)
open access
Real-world persistence with antifibrotic treatments: a nationwide study on claims data in France (The REPEAT study)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- TaILOR: a randomised trial to compare the clinical and cost-effectiveness of a patient-initiated follow-up (PIFU) strategy compared to standard care pathways in people with inflammatory arthritis: a study protocol.#354886
- Estimating causal effects of treatments in randomized and nonrandomized studies.#7363
- Zombie trials are often monocentric and cluster within fabricated evidence factories: a cohort study of 236 retracted randomized controlled trials with confirmed data fabrication#478021
- Safety and Effectiveness of Regorafenib#885063
- The Duty to Rescue and Randomized Controlled Trials Involving Serious Diseases#753931
Record · ID 330279
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive